More on MESO
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $15.68 |
|
|||
| Open | $15.86 | ||||
| 52 Wk High | $10.89 | ||||
| 52 Wk Low | $3.50 | ||||
| Day High | $16.34 | ||||
| Day Low | $15.66 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 296,433 | ||||
- Mesoblast Limited (MSB:AU) (MESO) PT Lowered to AUD3.23 at Canaccord
- Ryoncil® Profits Underpinning Substantial Growth Pipeline
- High Survival Rates With Ryoncil® in EIND Program Emphasize Importance of Earlier Use in Both Children and Adults With SR-aGvHD
- Ryoncil® Net Revenues Increase for the Quarter to US$30M
- Real-World Commercial Experience with Ryoncil® Shows 84% Survival of Children with SR-aGvHD After Completing 28-Days of Treatment
- FDA Acknowledges Effects on Pain Intensity Favor Rexlemestrocel-L, Confirms 12-Month Reduction in Back Pain Supports Product Efficacy
- Ryoncil® Sales Increase 60% in December Quarter to US$35.1M
- Mesoblast names Facchina as new chair, Bell to stay as director
- Mesoblast Announces Changes to Board of Directors' Leadership Roles
- Mesoblast files registration for warrant exercise shares
Entities mentioned with MESO
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- AdCom | View Related Stories »
- PDUFA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Pre Market Movers | View Related Stories »
- Carl Icahn | View Related Stories »
- Show More...
